Animal models for hepatocellular carcinoma

Area of Science:

• Oncology
• Hepatology
• Animal Models

Background:

• Hepatocellular carcinoma (HCC) is the most common primary liver cancer, predominantly affecting patients with chronic liver disease and cirrhosis.
• Accurate animal models are essential for both basic and translational research in HCC.
• Existing models include chemically-induced, genetically-engineered, and xenograft approaches, often used in combination.

Purpose of the Study:

• To review and discuss the necessity and development of animal models for hepatocellular carcinoma.
• To highlight the limitations of single-approach models and the advantages of combined insults.
• To explore strategies for creating more relevant HCC models that recapitulate human disease settings.

Main Methods:

• Review of current literature on chemically-induced, genetically-engineered, and xenograft animal models for HCC.
• Analysis of combined insult strategies, including chemical injury with metabolic disorders or alcohol.
• Discussion of genetically engineered models combined with disease-specific injuries.

Main Results:

• Single-approach animal models are insufficient to fully recapitulate human hepatocellular carcinoma.
• Combining pathogenic insults in animal models enhances their relevance to human disease etiology.
• Combining chemical injury with metabolic disorder or alcohol accelerates hepatocarcinogenesis in mice.
• Genetically engineered models with specific injuries show promise for mimicking distinct clinical settings of human HCC.

Conclusions:

• Developing multifaceted animal models is key to advancing hepatocellular carcinoma research.
• Combined insults in animal models offer a more realistic approach to studying liver cancer.
• Future models should integrate genetic engineering with specific disease-related injuries for improved translational value.